<table border="1"><tr><th>Trade names</th><td>Valcyte, Valcip, others</td></tr><tr><th>AHFS/Drugs.com</th><td>Monograph</td></tr><tr><th>MedlinePlus</th><td>a605021</td></tr><tr><th>License data</th><td>US |  DailyMed | Valganciclovir</td></tr><tr><th>Pregnancy | category</th><td>AU |  D</td></tr><tr><th>Routes of | administration</th><td>By mouth</td></tr><tr><th>ATC code</th><td>J05AB14 ( | WHO | )</td></tr><tr><th>Legal status</th><td>UK |  POM (Prescription only) | US |  ℞-only</td></tr><tr><th>Bioavailability</th><td>60%</td></tr><tr><th>Protein binding</th><td>1–2%</td></tr><tr><th>Metabolism</th><td>Hydrolysed to ganciclovir</td></tr><tr><th>Elimination | half-life</th><td>4 hours</td></tr><tr><th>Excretion</th><td>Kidney</td></tr><tr><th>Identifiers</th><td>IUPAC name | 2-[(2-amino-6-oxo-6,9-dihydro-3 | H | -purin-9-yl)methoxy]-3-hydroxypropyl-(2 | S | )-2-amino-3-methylbutanoate</td></tr><tr><th>CAS Number</th><td>175865-60-8</td></tr><tr><th>PubChem | CID</th><td>135413535</td></tr><tr><th>IUPHAR/BPS</th><td>4716</td></tr><tr><th>DrugBank</th><td>DB01610</td></tr><tr><th>ChemSpider</th><td>57721</td></tr><tr><th>UNII</th><td>GCU97FKN3R</td></tr><tr><th>KEGG</th><td>D02495 | as HCl | D03256</td></tr><tr><th>ChEMBL</th><td>ChEMBL1201314</td></tr><tr><th>NIAID ChemDB</th><td>032967</td></tr><tr><th>PDB ligand</th><td>F9E ( | PDBe | , | RCSB PDB | )</td></tr><tr><th>CompTox Dashboard | ( | EPA | )</th><td>DTXSID8048288</td></tr><tr><th>Formula</th><td>C | 14 | H | 22 | N | 6 | O | 5</td></tr><tr><th>Molar mass</th><td>354.367 |  g·mol | −1</td></tr><tr><th>3D model (JSmol)</th><td>Interactive image</td></tr></table>